Search Results - "Iyer, Nikita"
-
1
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Published in Cell reports (Cambridge) (10-08-2021)“…We describe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses, soluble markers of inflammation, and antibody levels and…”
Get full text
Journal Article -
2
Tunable Fano‐Resonant Metasurfaces on a Disposable Plastic‐Template for Multimodal and Multiplex Biosensing
Published in Advanced materials (Weinheim) (01-05-2020)“…Metasurfaces are engineered nanostructured interfaces that extend the photonic behavior of natural materials, and they spur many breakthroughs in multiple…”
Get full text
Journal Article -
3
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
Published in Nature biotechnology (01-08-2021)“…Current serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies mainly take the form of enzyme-linked immunosorbent assays,…”
Get full text
Journal Article -
4
Genome‐wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID‐19
Published in Journal of leukocyte biology (01-07-2021)“…The global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a highly pathogenic RNA virus causing coronavirus disease…”
Get full text
Journal Article -
5
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
Published in Cells (Basel, Switzerland) (13-02-2021)“…As the SARS-CoV-2 pandemic continues, reports have demonstrated neurologic sequelae following COVID-19 recovery. Mechanisms to explain long-term neurological…”
Get full text
Journal Article -
6
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Published in Science advances (30-07-2021)“…Interpretation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveillance studies is limited by poorly defined performance of antibody…”
Get full text
Journal Article -
7
Chronic viral coinfections differentially affect the likelihood of developing long COVID
Published in The Journal of clinical investigation (01-02-2023)“…BACKGROUNDThe presence and reactivation of chronic viral infections, such as EBV, CMV, and HIV, have been proposed as potential contributors to long COVID…”
Get full text
Journal Article -
8
Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease
Published in Open forum infectious diseases (01-08-2021)“…Abstract We report a patient with connective tissue disease who developed modest severe acute respiratory syndrome coronavirus 2 receptor binding…”
Get full text
Journal Article -
9
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody
Published in Nature communications (09-03-2022)“…A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells…”
Get full text
Journal Article -
10
Biosensing: Tunable Fano‐Resonant Metasurfaces on a Disposable Plastic‐Template for Multimodal and Multiplex Biosensing (Adv. Mater. 19/2020)
Published in Advanced materials (Weinheim) (01-05-2020)“…Metasurface fabrication techniques are costly and time consuming since they require multiple complex deposition and patterning steps to build devices with only…”
Get full text
Journal Article -
11
Tunable Fano-resonant Metasurfaces on a Disposable Plastic-template for Multi-modal and Multiplex Biosensing
Published in Advanced materials (Weinheim) (23-03-2020)“…Metasurfaces are engineered nanostructured interfaces that extend photonic behaviorof natural materials, and they spurred many breakthroughs in multiple…”
Get full text
Journal Article -
12
First-in-human immunoPET imaging of HIV-1 infection using 89 Zr-labeled VRC01 broadly neutralizing antibody
Published in Nature communications (09-03-2022)“…A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells…”
Get full text
Journal Article